ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,081.93
0.12%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IDEAYA Biosciences Inc (IDYA)

  7. IDEAYA Biosciences Inc (IDYA) News

IDEAYA Biosciences (IDYA)

IDEAYA Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IDYA
DateTimeSourceHeadlineSymbolCompany
03/06/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
03/06/202411:00PR Newswire (US)IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant StudyNASDAQ:IDYAIDEAYA Biosciences Inc
31/05/202421:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
31/05/202421:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
31/05/202421:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
31/05/202411:00PR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
29/05/202422:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
29/05/202411:00PR Newswire (US)IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations EventsNASDAQ:IDYAIDEAYA Biosciences Inc
28/05/202411:00PR Newswire (US)IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business DevelopmentNASDAQ:IDYAIDEAYA Biosciences Inc
24/05/202402:21PR Newswire (US)/C O R R E C T I O N -- IDEAYA Biosciences, Inc./NASDAQ:IDYAIDEAYA Biosciences Inc
23/05/202422:05PR Newswire (US)IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal MelanomaNASDAQ:IDYAIDEAYA Biosciences Inc
07/05/202411:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
07/05/202411:00PR Newswire (US)IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
01/05/202411:00PR Newswire (US)IDEAYA Biosciences to Participate in Upcoming May 2024 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
26/04/202411:00PR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
24/04/202415:05PR Newswire (US)IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored StudyNASDAQ:IDYAIDEAYA Biosciences Inc
22/04/202411:00PR Newswire (US)IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung CancerNASDAQ:IDYAIDEAYA Biosciences Inc
05/04/202411:00PR Newswire (US)IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IDYAIDEAYA Biosciences Inc
01/04/202411:00PR Newswire (US)IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations EventNASDAQ:IDYAIDEAYA Biosciences Inc
12/03/202410:00PR Newswire (US)IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial CancerNASDAQ:IDYAIDEAYA Biosciences Inc
04/03/202422:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
04/03/202422:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
04/03/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
04/03/202411:00PR Newswire (US)IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations EventsNASDAQ:IDYAIDEAYA Biosciences Inc
20/02/202421:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IDYAIDEAYA Biosciences Inc
20/02/202411:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IDYAIDEAYA Biosciences Inc
20/02/202411:00PR Newswire (US)IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business UpdateNASDAQ:IDYAIDEAYA Biosciences Inc
14/02/202411:44Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IDYAIDEAYA Biosciences Inc
14/02/202400:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IDYAIDEAYA Biosciences Inc
13/02/202421:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IDYAIDEAYA Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IDYA

Your Recent History

TSXV
MOON
Blue Moon Metals
NYSE
NGL
NGL Energy Partners
BIT
SUAS
Exchange Traded
LSE
IFX3
3x Infineon
BIT
P1SLA0
BNP Paribas Issuance
BIT
P1KFN2
BNP Paribas Issuance
BIT
P1U9X0
BNP Paribas Issuance
BIT
P1SXJ6
BNP Paribas Issuance
ASX
SCDHB
Standard Chartered
BIT
P1U7R6
BNP Paribas Issuance
NYSE
RBAC
RedBall Acquisition
BIT
UC6MQT
Unicredit Bank
BIT
P1U2G0
NLBNPIT1U2G0 20240621 32...
NASDAQ
ABAIAXX
Jpmorgan Chase Financial...
LBNK
MBDUSDT
Mobydick
COIN
FITTTTUST
FIT Token
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved